Letairis

Generic name: Ambrisentan
Drug class: Agents for pulmonary hypertension

Usage of Letairis

Letairis prevents thickening of the blood vessels, especially those in the lungs and heart. Ambrisentan also lowers blood pressure in your lungs, helping your heart pump blood more efficiently.

Letairis is used to treat pulmonary arterial hypertension (PAH) in adults. It improves your ability to exercise and prevents your condition from getting worse.

Letairis is sometimes used with a medicine called tadalafil (Adcirca).

For women, Letairis is available only from a certified pharmacy under a special program. You must be registered in the program and sign agreements to use birth control and undergo pregnancy and blood testing.

Letairis side effects

Get emergency medical help if you have signs of an allergic reaction to Letairis: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

severe shortness of breath, wheezing, cough with foamy mucus, chest pain;

swelling, tiredness, rapid weight gain;

low red blood cells (anemia) - pale skin, unusual tiredness, feeling light-headed or short of breath, cold hands and feet; or

liver problems - loss of appetite, stomach pain (upper right side), nausea, vomiting, fever, itching, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).

Common Letairis side effects may include:

swelling in your hands, legs, ankles, or feet;

stuffy nose, sinus pain; or

hot flashes, redness in your face.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Letairis

You should not use Letairis if you are allergic to ambrisentan, or if you have idiopathic pulmonary fibrosis (IPF).

Do not use Letairis if you are pregnant or think you might be pregnant. This medicine can cause serious birth defects. Tell your doctor right away if you miss a menstrual period or think you may have become pregnant.

You will need to have a negative pregnancy test before starting this treatment. You will be re-tested every month during your treatment, and 1 month after your last dose.

Even if you are not planning a pregnancy, you are considered able to become pregnant if:

you have entered puberty (even if you have not yet started having periods);

you have never had a hysterectomy or had your ovaries removed; or

you have not gone through menopause (you have never gone 12 months in a row without a menstrual period).

While taking Letairis and for at least 30 days after your last dose, you must use a highly effective form of birth control or two methods together.

Recommended forms of birth control forms include:

a tubal ligation, or a copper IUD (intrauterine device) or progesterone implant;

one hormone form (birth control pill, skin patch, implant, vaginal ring, or injection) plus 1 barrier form (condom, diaphragm with spermicide, or cervical cap with spermicide);

a condom and a female barrier form together (diaphragm with spermicide, or cervical cap with spermicide); or

a partner's vasectomy plus 1 hormone form or 1 barrier form.

Letairis comes with patient instructions about acceptable forms of birth control to use while taking this medicine. Follow these directions carefully. Ask your doctor about emergency contraception if you have unprotected sex or if you believe your contraception has failed.

To make sure Letairis is safe for you, tell your doctor if you have ever had:

liver disease; or

anemia (low red blood cell counts).

You should not breastfeed while you are using ambrisentan.

Ambrisentan may lower a man's sperm count and could affect fertility (your ability to have children).

Relate drugs

How to use Letairis

Usual Adult Dose for Pulmonary Hypertension:

Initial dose: 5 mg orally once a day. Comments: -Consider increasing the dose to 10 mg orally once a day if 5 mg is tolerated. -When used with tadalafil, the dose of either drug can be increased as needed and tolerated at 4-week intervals. Uses: -For the treatment of pulmonary arterial hypertension (WHO Group 1) to improve exercise ability and delay clinical worsening. -For the treatment of pulmonary arterial hypertension (WHO Group 1) in combination with tadalafil to reduce the risks of disease progression and hospitalization for worsening pulmonary arterial hypertension, and to improve exercise ability.

Warnings

Letairis can harm an unborn baby or cause birth defects. Do not use if you are pregnant. You will need to take a pregnancy test before, during, and after treatment with ambrisentan.

If you are a woman of child-bearing potential, you will be required to use two forms of birth control to prevent pregnancy during your treatment, and for at least 1 month after your treatment ends.

You should not use Letairis if you have idiopathic pulmonary fibrosis.

What other drugs will affect Letairis

Tell your doctor about all your other medicines, especially:

cyclosporine.

This list is not complete. Other drugs may interact with ambrisentan, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.